Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 342,000 | 546,000 | 86,100 | 488,400 | -1,008,700 |
| Depreciation Amortization | 137,000 | 431,000 | 0 | 0 | 0 |
| Other Working Capital | -28,000 | -218,000 | -291,700 | -375,400 | -9,200 |
| Other Operating Activity | 48,000 | 1,299,000 | 1,499,200 | 99,300 | 1,306,400 |
| Operating Cash Flow | $499,000 | $2,058,000 | $1,293,600 | $212,300 | $288,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -156,000 | -390,000 | -237,000 | -89,600 | -71,500 |
| Net Acquisitions | 0 | -3,587,000 | -3,582,300 | -24,300 | -3,556,300 |
| Other Investing Activity | -541,000 | -81,000 | -272,400 | -218,200 | 443,400 |
| Investing Cash Flow | $-697,000 | $-4,058,000 | $-4,091,700 | $-332,100 | $-3,184,400 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -72,000 | -229,000 | -169,800 | -56,600 | -54,700 |
| Other Financing Activity | 108,000 | 2,253,000 | 2,519,100 | 74,700 | 2,639,400 |
| Financing Cash Flow | $36,000 | $2,024,000 | $2,349,300 | $18,100 | $2,584,700 |
| Exchange Rate Effect | 6,000 | 32,000 | 6,700 | -3,500 | 3,900 |
| Beginning Cash Position | 1,332,000 | 1,276,000 | 1,275,600 | 968,300 | 1,275,600 |
| End Cash Position | 1,176,000 | 1,332,000 | 833,500 | 863,100 | 968,300 |
| Net Cash Flow | $-156,000 | $56,000 | $-442,100 | $-105,200 | $-307,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 499,000 | 2,058,000 | 1,293,600 | 212,300 | 288,500 |
| Free Cash Flow | 499,000 | 2,058,000 | 1,293,600 | 212,300 | 288,500 |